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Impaired aortic distensibility and elevated
central blood pressure in Turner Syndrome:
a cardiovascular magnetic resonance study
Jan Wen1, Christian Trolle1, Mette H. Viuff1, Steffen Ringgaard2, Esben Laugesen1, Ephraim J. Gutmark3,4,
Dhananjay Radhakrishnan Subramaniam3, Philippe Backeljauw5, Iris Gutmark-Little5, Niels H. Andersen6,
Kristian H. Mortensen7 and Claus H. Gravholt1,8*
Abstract
Background: Women with Turner Syndrome have an increased risk for aortic dissection. Arterial stiffening is a risk
factor for aortic dilatation and dissection. Here we investigate if arterial stiffening can be observed in Turner Syndrome
patients and is an initial step in the development of aortic dilatation and subsequent dissection.
Methods: Fifty-seven women with Turner Syndrome (48 years [29–66]) and thirty-six age- and sex-matched controls
(49 years [26–68]) were included. Distensibility, blood pressure, carotid-femoral pulse wave velocity (PWV), the
augmentation index (Aix) and central blood pressure were determined using cardiovascular magnetic resonance,
a 24-h blood pressure measurement and applanation tonometry. Aortic distensibility was determined at three
locations: ascending aorta, transverse aortic arch, and descending aorta.
Results: Mean aortic distensibility in the descending aorta was significantly lower in Turner Syndrome compared
to healthy controls (P = 0.02), however, this was due to a much lower distensibility among Turner Syndrome with
coarctation, while Turner Syndrome without coarctation had similar distensibility as controls. Both the mean heart
rate adjusted Aix (31.4% vs. 24.4%; P = 0.02) and central diastolic blood pressure (78.8 mmHg vs. 73.7 mmHg;
P = 0.02) were higher in Turner Syndrome compared to controls, and these indices correlated significantly with
ambulatory night-time diastolic blood pressure. The presence of aortic coarctation (r = − 0.44, P = 0.005) and a
higher central systolic blood pressure (r = − 0.34, P = 0.03), age and presence of diabetes were inversely
correlated with aortic distensibility in TS.
Conclusion: Aortic wall function in the descending aorta is impaired in Turner Syndrome with lower distensibility
among those with coarctation of the aorta, and among all Turner Syndrome higher Aix, and elevated central
diastolic blood pressure when compared to sex- and age-matched controls.
Trial registration: The study was registered at ClinicalTrials.gov (#NCT01678274) on September 3, 2012.
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Introduction
Turner Syndrome is the second most common chromo-
somal aneuploidy in females, occurring in 1 out of 2000
live births [1]. Women with Turner Syndrome face a
100-fold increased risk of aortic dissection [2, 3], which,
along with a high incidence of coronary heart disease,
hypertension, stroke and congenital heart disease may
detrimentally impact life expectancy [4–6]. Factors asso-
ciated with the often fatal aortic dissection include aortic
dilatation [2], hypertension [7], bicuspid aortic valve
(BAV) [8], 45,X karyotype, and coarctation of the aorta
(CoA) [3, 9–11]. Unfortunately, these known risk factors
fail to predict all events of aortic dissection [12], and
there is a need to improve risk stratification beyond
measuring aortic diameter and assessing aortic growth.
A risk factor that considers the dynamic properties of
aortic wall function could result in better prediction of
dissection and rupture risk. Cardiovascular magnetic
resonance imaging (CMR) can locally assess aortic dis-
tensibility. A prior study found reduced aortic distensi-
bility in adolescents with Turner Syndrome at the level
of the pulmonary artery bifurcation and the level of the
diaphragm [13]. Increased arterial stiffness could there-
fore be a part of the pathophysiology behind the high
prevalence of aortic disease in Turner Syndrome [14].
Hence, assessment of arterial stiffness may help elucidate
impaired arterial function to better understand aortic
disease and ultimately to improve the identification of
patients with aortic dilation and hopefully to improve
prognostication of this group of patients, as shown in
other populations [15, 16].
The aim of this study was to investigate arterial stiff-
ness and hemodynamic parameters, such as blood pres-
sure, carotid-femoral pulse wave velocity (PWV), the
augmentation index (Aix), central blood pressure, rate of
dilation of the aorta and distensibility in the thoracic
aorta in adults with Turner Syndrome, compared to
healthy controls.
Methods
Study population
Females with karyotype-proven Turner Syndrome and
age- and sex-matched controls were enrolled into this
cross-sectional study from a prospective study of cardio-
vascular health in Turner Syndrome [11, 17, 18]. The
participants had been recruited through the Danish Na-
tional Society of Turner Syndrome Contact Group and
an endocrine outpatient clinic. Exclusion criteria were
malignancy, liver disease, contraindications to CMR, and
pregnancy. Out of 67 eligible participants, fifty-seven
completed this study, with exclusions due to CMR con-
traindications (n = 1), claustrophobia (n = 1), prior Bentall
procedure (n = 1), suboptimal image quality with repeat
CMR declined (n = 2), and aortic valve prosthesis (n = 6).
Out of 39 eligible healthy age-matched controls, 36
completed the study with exclusions due to claustropho-
bia (n = 1) and suboptimal image quality with repeat CMR
declined (n = 2). All examinations were performed during
the same day.
Pulse wave velocity (PWV) and pulse wave analysis
(experiment 1)
In a first experiment pulse waves were recorded in the
carotid and the femoral artery using a SphygmoCor
(SPT-301B; Millar, Houston, Texas, USA) in combination
with an applanation tonometer. Based on non-invasive re-
cordings of the pulse waves, central blood pressure and
carotid femoral pulse wave velocity can be determined.
The investigation was performed between 7.30 A.M. and
9.30 A.M. following an overnight fast. Participants were
instructed not to smoke or ingest caffeinated beverages at
least 3 h before the examinations. Two of the investigators
(JW and CT) performed all measurements with the pa-
tient in the supine position in a temperature-controlled
room after > 5 min of rest.
Carotid-femoral PWV
PWV calculation is based on recording travel speed of
the pulse wave generated by cardiac contraction over a
known distance and is reported as meters/second. With
the SphygmoCor system, the carotid PWV is calculated
by so-called sequential electrocardiogram (ECG)-gated
pulse wave recordings: With the patient in the supine
position, three ECG electrodes were applied allowing the
recording of R-waves. The distance between the supras-
ternal notch and the carotid pulse mark and the distance
between the suprasternal notch and the femoral pulse
mark were measured and entered into the SphygmoCor
software. The software then subtracted the suprasternal
notch-carotid distance from the suprasternal notch-fem-
oral distance (dist_subtr). The pulse wave at the carotid
artery was then recorded by the tonometer, and the time
delay between the R-wave and the arrival of the pulse
wave at the carotid artery was stored. Then pulse wave
was recorded at the femoral artery, and the time delay
between the R-wave and the arrival of the pulse wave at
the femoral artery was stored. The software then sub-
tracted the travel time of the recorded R-wave to the ca-
rotid artery from the travel time of the recorded R-wave
to the femoral artery (=travel time, subtr) and calculated
the carotid-femoral PWV as (dist, subtr)/(travel time,
subtr). The transit time was determined by the intersecting
tangent algorithm method [19], as recommended by the
manufacturer (www.atcormedical.com.au/download/
Active/Research_Manual_(CVMS).pdf ). The Sphygmo-
Cor equipment averages the pulse wave velocity over mul-
tiple heart cycles during 10 s of recordings. Distances
were measured using a slide gauge. At least two PWV
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measurements were obtained, accepting a standard devi-
ation< 20% for each individual PWV measurement, which
is typically composed of the average of 7–8 heart beats.
Quality control excluded nine individuals with Turner
Syndrome and six controls from the PWV [20], and in five
individuals with Turner Syndrome and one control, we
could not technically measure PWV. Fifteen individuals
with Turner Syndrome and five controls were excluded
from the PWV analysis due to an Operator Index ≤80,
and three Turner Syndrome individuals were technically
impossible to measure. Therefore, 49 participants with
Turner Syndrome and 34 controls had valid data for PWV
analysis.
Pulse wave analysis
The PWV at the radial artery was recorded non-invasively
during 10 s by the Millar tonometer. Based on recordings
of the radial pulse wave, blood pressure in the ascending
aorta was computed using the inbuilt transfer function of
the SphygmoCor software [21]. The computations were
calibrated by cuff-based brachial systolic and diastolic
blood pressure as recommended by the manufacturer.
Blood pressure was measured by a Riester Champion N
automatic blood pressure monitor three times and aver-
aged (Riester GmbH, Jungingen, Germany). Before blood
pressure measurements, arm circumference was mea-
sured with a tape measure and an appropriately sized
cuff was used.
The Aix is an expression of the augmentation of the
blood pressure in the ascending aorta from reflecting
waves adding to the blood pressure generated from the
systolic contraction. The Aix in the ascending aorta was
computed based on the recordings at the radial artery.
The pressure arising from the reflected waves is termed
the augmentation pressure. The sum of the forward
and the reflected waves is the central pulse pressure.
The central Aix was calculated as the augmentation
pressure divided by the central pulse pressure and thus
expressed the augmentation pressure as a percentage of
the pulse pressure [19, 22]. Aix was adjusted for heart
rate by linear regression.
Pulse wave analysis measurements with an operator
index (measure of both waveform reproducibility and
signal strength) of ≤80 was excluded as recommended
by the vendor [22].
Aortic distensibility (experiment 2)
At 11 A.M. CMR was performed on a 1.5 Tesla
CMR (Achieva-dStream, Philips Healthcare, Best,
The Netherlands) scanner using the standard anter-
ior and posterior coils. Aortic distensibility was de-
rived from 2D cine images acquired with a balanced
steady-state-free-precession (bSSFP) sequence using
retrospective electrocardiogram (ECG) gating. Repetition
time was 3.6 ms and echo time was 1.8 ms. Depending on
heart rate, 19 to 24 cardiac frames were acquired in a 14 s
breath-hold. Slice thickness was 6 mm, field-of-view was
313 × 313 mm2 and pixel size was 1.6 × 1.6 mm2. Three
imaging planes were acquired perpendicular to the aortic
wall at: 1) the ascending aorta at the level of the main pul-
monary artery bifurcation, 2) the transverse aortic arch,
and 3) the descending aorta at the level of the main pul-
monary artery bifurcation (Fig. 1a). The arterial blood
pressure for distensibility calculation was measured before
and after the scan with the patient lying on the scanner
bed, using a CMR compatible sphygmomanometer (Aner-
oid, ERKA, Germany). Average blood pressure from the
two measurements was used in subsequent computations.
Aortic distensibility AoD was calculated as:
AoD ¼ ΔA
ΔP∙Adia
where ΔA is the difference between the maximum and
minimum cross-sectional aortic area over the cardiac
cycle, ΔP is the difference between systolic and diastolic
blood pressures, and Adia is the diastolic cross-sectional
aortic area [23]. The cross-sectional areas were obtained
by semi-automatic segmentation of the vessel through
all cardiac frames using the Siswin® software (Steffen
Ringgaard, Aarhus, Denmark). The vessel lumen was
manually selected by a single point within the vessel in
one frame, and the vessel edge was determined as the
maximum image intensity gradient found radially from
this point. Edge point outliers were removed, and an el-
lipse was fitted to the edge points. The automatic vessel
selections were visually inspected and manually cor-
rected where necessary (Fig. 1b). The variation of aortic
area over the cardiac cycle is shown in Fig. 1c. All partic-
ipants were examined by the same staff and in the same
scanner. The scans were analysed in two bulks. Scans
were analysed in duplicates following anonymization
using digest package in R (3.1.0 Foundation for Statis-
tical Computing, Vienna, Austria). One scan was ana-
lysed 10 times to determine intra-observer variability of
distensibility (coefficient of variation: 10% at the as-
cending aorta, 8% at the aortic arch, and 11% at the
descending aorta).
Echocardiography and anatomical CMR (experiment 3)
As previously described and presented elsewhere [17, 24],
transthoracic echocardiography was performed by a single
observer on a GE Vivid 7 (GE Healthcare, Horten,
Norway), with a 2.5 MHz transducer using second har-
monic imaging. Aortic valve morphology and function were
noted.
Aortic arch anomalies were determined from a 3D bSSFP
diastolic-triggered and respiratory-gated non-contrast
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enhanced sequence [17, 24]. Aortic arch anomalies were di-
agnosed as 1) aortic coarctation when there was a shelf-like
narrowing of the aortic lumen in the region of the aortic
isthmus (Fig. 1d), and 2) elongated transverse aortic arch
when the arch appeared elongated with a kink of the
inferior curvature at the aortic isthmus. Echocardiog-
raphy and CMR angiography were performed to define
anomalies of the aortic valve and thoracic aorta [24],
which included bicuspid aortic valve (BAV) and elon-
gated transverse aortic arch (ETA).
In addition, we have examined these Turner Syndrome
women over a period of 10 years and have determined the
rate of dilation of the aorta from t = 0 to t = 10 years at
nine positions: (i) aortic sinuses (measuring cusp-
to-opposing-cusp diameter at the point of the maximum
aortic diameter in the aortic sinus); (ii) the sinotubular
junction; (iii) mid-ascending aorta at the level of the infer-
ior margin of right pulmonary artery; (iv) distal ascending
aorta immediately proximal to brachiocephalic artery; (v)
proximal aortic arch between the brachiocephalic and left
carotid artery arteries; (vi) distal aortic arch immediately
proximal to left subclavian artery; (vii) aortic isthmus im-
mediately distal to the left subclavian artery; (viii) prox-
imal descending aorta between the left pulmonary artery
and the top of left atrium; and (ix) distal descending aorta
at the most caudal border of the left atrium [18]. These
data have been added to the results.
Blood pressure and associated cardiovascular features
(experiment 4)
Following experiment 2 and 3, 24 h ambulatory blood pres-
sures were obtained with oscillometric measurements every
20 min (Spacelabs 90,217, Spacelabs Healthcare, Issaquah,
Washington, USA). The cuff was placed on the left upper
arm in all participants, and the cuff size was adjusted to the
A
B
C
D
Fig. 1 a Illustration of the three separate imaging slices used for
balanced steady state free precession (bSSFP) cine imaging on a
representative sagittal reformat of the 3D volume used for planning.
The imaging slices were positioned perpendicular to the aortic wall in
the mid-ascending aorta (at the level of the pulmonary bifurcation),
the transverse aortic arch arch (after the left common carotid artery)
and the proximal descending aorta (at the level of the pulmonary
arterial bifurcation which was after any aortic coarctation in all).
b Sample frame from a 2D bSSFP cine image for measurement of
aortic distensibility in the ascending aorta, demonstrating the
contouring. c The aortic area variation over the cardiac cycle with
time (ms) on the x-axis and cross-sectional is (mm2) on the y-axis.
ED – end diastole, ES – end systole. d The diagnosis of aortic coarctation
was made from non-contrast enhanced diastolic 3D data sets used for
the planning of the bSSFP cine imaging planes. The diagnosis was based
on the presence of a shelf-like constriction of the aortic lumen at the
aortic isthmus. This is shown here in modified sagittal and coronal
reformats in a female with Turner syndrome who has luminal narrowing
(arrow) with post-stenotic dilatation of the descending aorta (DAo)
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arm circumference. Fasting blood samples were drawn.
Height, weight and medical history were recorded.
Statistics
Statistical analysis was performed using Stata/IC 13.1
(StataCorp LP, College Station, Texas, USA). Nor-
mality was assessed by Q-Q plots of absolute or
log-transformed values, and box-plots were scruti-
nized for outliers. Student’s independent t-test (given
as mean ± SD or for transformed values, as geomet-
ric mean with confidence interval) or Mann–Whit-
ney U-test (given as median with range) were used
as appropriate. Repeated measurements were
assessed using analysis of variance (ANOVA) testing
the interaction between group (Turner Syndrome or
control) and aortic position, reporting the Box’s con-
servative P-value. Assumptions were checked by
Q-Q plot of the residuals, assessment of the covari-
ance matrix, and assessment of sphericity. Compari-
sons of nominal variables were performed using the
Fisher’s exact test. Bivariate correlations were
assessed using Pearson’s coefficient of correlation.
Explanatory models were constructed for aortic dis-
tensibility using multiple linear regression analyses.
Independent variables were chosen from the bivari-
ate correlation analyses of continuous variables. In-
dependent variables were omitted from the models
when p > 0.10. The contribution of each variable to
the final model is stated as standardized coefficients
(β). Assumptions behind the regression models were
checked by Q-Q plots of the residuals, plotting re-
siduals versus fitted, residuals versus each of the in-
dependent variables, box-plots, and leverage plots. A
p-value < 0.05 was considered statistically significant.
Results
The mean age for Turner Syndrome women was
47.5 years [29–66] of which 60% (n = 34) had 45,X mono-
somy and 40% (n = 23) were mosaics. Thirty-six healthy
women, with a median age of 48.7 years [26–68; p = 0.9],
served as controls (Table 1). Between-group differences
were found for body mass index (BMI), body surface area
(BSA), height, and night-time diastolic blood pressure
(Table 1). Eleven women with Turner Syndrome had
BAV (19%), eight (14%) had a repaired coarctation (CoA),
and 26 (46%) had an ETA. Ten women with Turner Syn-
drome (18%) had type 2 diabetes, 28 (49%) were on anti-
hypertensive treatment, and nine (16%) were treated with
a statin. Mean plasma levels of high-density lipoproteins,
low-density lipoproteins, triglycerides, and glycated
haemoglobin (HbA1C) did not differ between groups. Five
controls (14%) were treated for hypertension and one (3%)
received a statin. None in the control group had diabetes.
Pulse wave analysis, PWV and central blood pressure
(experiment 1 and 4)
Central diastolic blood pressure and night-time diastolic
blood pressure were significantly raised in Turner Syn-
drome (Table 1), and 24-h ambulatory diastolic blood
pressure correlated with central diastolic blood pressure
(r = 0.6, p = 0.0001. Figure 2) and heart rate adjusted
Aix. The 24-h systolic blood pressure measurements re-
vealed comparable day and night-time values in Turner
Syndrome and controls. Heart rate adjusted Aix (Table 2)
was higher in Turner Syndrome compared to controls
(p ≤ 0.03) even when excluding women with CoA, whilst
PWV was comparable (p = 0.6).
Aortic distensibility, rate of dilation of the aorta and
aortic area (experiment 2 and 3)
The overall distensibility throughout the aorta differed
between Turner Syndrome and controls (interaction be-
tween group and aortic position; p = 0.042). There was
no site-specific difference in the ascending aorta and in
the aortic arch, while aortic distensibility was reduced in
the descending aorta in Turner Syndrome (p = 0.02)
(Table 3, Fig. 3). Aortic distensibility was significantly
lower in women with CoA (n = 8), both in the ascending
aorta and descending aorta when compared to those
without CoA (Table 3 and Additional file 1: Figure S1).
Excluding women with CoA from the comparison of
Turner Syndrome and controls left only a trend towards
a lower distensibility at the descending aorta (p = 0.1;
Table 3, Additional file 1: Figure S2). Turner Syndrome
subgroups divided according to karyotype (p = 0.5),
aortic valve morphology (p = 0.4) and the presence of
an ETA (p = 0.5) were comparable for aortic distensi-
bility, while Turner Syndrome with type 2 diabetes
had significantly lower aortic distensibility at all sites
(all p < 0.05), also when only studying patients with
CoA in the ascending aorta and arch (all p < 0.05).
Associations between distensibility, blood pressure, rate
of aortic diameter and other measures
Within the Turner Syndrome group, central systolic
blood pressure (ascending: r = − 0.45, p = 0.002; de-
scending: r = − 0.34, p = 0.03), CoA (r = − 0.30, P = 0.02;
r = − 0.41, p = 0.0013), and Aix (r = − 0.35, P = 0.02;
r = − 0.31, p = 0.04) correlated with distensibility in the
ascending and descending aorta, respectively, whereas
BMI, BSA and central diastolic blood pressure did not
(all p > 0.6). Only central systolic blood pressure corre-
lated significantly with distensibility in the aortic arch.
Age was strongly correlated with aortic distensibility at all
levels in both Turner Syndrome and controls (all p < 0.001).
When including these significant variables in a multiple lin-
ear regression model of the descending aorta, only CoA
and age remained significantly explanatory variables of
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distensibility (β = − 0.42, p = 0.001; Table 4), while only age
remained a significant explanatory variable of distensibility
at the level of the ascending aorta and the arch (β = − 0.52
and β = − 0.47, both p < 0.001).
In separate analyses, we assessed the association be-
tween distensibility and the rate of change in aortic
diameter during 10 years follow-up at anatomically-
linked predefined thoracic sites. Ascending aortic
Table 1 Anthropometrics and baseline descriptives in Turner syndrome and age and gender-matched controls, and Turner
syndrome without CoA (Coarctation of Aorta) and Turner syndrome with CoA
Turner Syndrome
(n = 57)
Controls
(n = 36)
P value† Turner Syndrome
without CoA (n = 49)
Turner Syndrome
with CoA (n = 8)
P value‡
Age [years] 46.1 ± 10.2 46.0 ± 12.9 0.9 45.9 ± 10.2 47.1 ± 10.3 0.8
Weight [kg] 62.5 ± 14.6 71.2 ± 13.5 0.01 61.8 ± 14.3 66.9 ± 16.4 0.4
Height [cm] 147.2 ± 6.7 169.3 ± 6.4 < 0.001 147.0 ± 7.1 148.1 ± 3.8 0.7
Body Mass Index [kg/m2] 28.9 ± 6.7 24.9 ± 4.6 0.001 28.6 ± 6.6 30.5 ± 7.3 0.5
Body Surface Area 1.5 ± 0.2 1.8 ± 0.2 < 0.001 1.5 ± 0.2 1.6 ± 0.2 0.4
24 h systolic Blood
Pressure [mmHg]a
117.9 ± 12.7 115.2 ± 10.7 0.3 117.5 ± 13.0 120.1 ± 11.6 0.6
24 h diastolic Blood
Pressure [mmHg]a
74.5 ± 10.2 71.7 ± 6.6 0.1 74.3 ± 9.9 75.3 ± 12.5 0.8
Day-time systolic Blood
Pressure [mmHg]a
123.4 ± 13.5 121.4 ± 10.6 0.5 122.8 ± 13.5 126.6 ± 14.2 0.5
Day-time diastolic Blood
Pressure [mmHg]a
78.6 ± 11.4 76.9 ± 6.5 0.4 78.3 ± 10.7 80.3 ± 15.1 0.7
Night-time systolic Blood
Pressure [mmHg]a
106.4 ± 11.9 103.3 ± 11.1 0.2 106.4 ± 12.6 106.4 ± 8.2 1
Night-time diastolic Blood
Pressure [mmHg]a
66.2 ± 8.6 61.5 ± 7.1 0.01 66.3 ± 8.7 65.6 ± 8.9 0.9
Systolic Blood pressure, Sphygmocor
(right)
121.3 ± 12.9 119.4 ± 13.8 0.5 120.7 ± 13.3 125.1 ± 10.0 0.4
Diastolic Blood pressure, Sphygmocor
(right)
77.6 ± 9.8 72.1 ± 8.8 0.007 77.3 ± 10.1 79.4 ± 8.8 0.6
Systolic Blood pressure, Sphygmocor
(left)
118.2 ± 13.8 118.4 ± 14.0 1.0 117.8 ± 14.3 120.6 ± 10.1 0.6
Diastolic Blood pressure, Sphygmocor
(left)
76.3 ± 9.4 71.3 ± 9.0 0.01 76.2 ± 9.4 77.1 ± 10.3 0.8
Low Density Lipids [mmol/L]b 2.6 ± 0.8 2.6 ± 0.9 0.9 2.7 ± 0.8 2.6 ± 0.9 0.9
High Density Lipids [mmol/L]b 1.8 ± 0.6 1.8 ± 0.5 0.8 1.8 ± 0.5 1.7 ± 0.7 0.9
Triglycerides [mmol/L]b 1.1 ± 0.7 1.1 ± 1.0 0.8 1.1 ± 0.6 1.4 ± 0.9 0.2
HbA1C [mmol/mol]b 36.0 [28.0–70.0] 35.5 [26.0–48.0] 0.2 36.0 [28.0–62.0] 38.4 [31.0–70.0] 0.3
Bicuspid aortic valvec 19% (11/57) 0% (0/36) 0.006 12% (6/49) 63% (5/8) 0.005
Coarctation of the aortac 14% (8/57) 0% (0/36) 0.02 0% (0/49) 100% (8/8) < 0.001
Elongated transverse aortac 46% (26/57) 0% (0/36) < 0.001 43% (21/49) 63% (5/8) 0.3
Type 2 Diabetesc 18% (10/57) 0% (0/36) 0.006 12% (6/49) 50% (4/8) 0.03
Statinsc 16% (9/57) 3% (1/36) 0.08 14% (7/49) 25% (2/8) 0.4
Aspirinc 5% (3/57) 0% (0/36) 0.3 6% (3/49) 0% (0/8) 0.6
Antihypertensivesc 49% (28/57) 14% (5/36) < 0.001 49% (24/49) 50% (4/8) 0.6
Hormone replacement
treatmentc
72% (41/57) 3% (1/36) < 0.001 73% (36/49) 63% (5/8) 0.4
Blood pressure marked with SphygmoCor where used to calibrated measurements done with the SphygmoCor equipment
afor Turner syndrome: n = 50, for controls: n = 34. For Turner syndrome without CoA: n = 42
bfor Turner syndrome: n = 56, for controls: n = 36. For Turner syndrome without CoA: n = 48
cFisher’s Exact Test
†: p-value for the comparison between the entire TS cohort and controls
‡: p-value for the comparison between TS without CoA and TS with CoA
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distensibility did not correlate with rate of change in
aortic diameter at any of the nearby assessed sites. Arch
distensibility correlated with rate of change in aortic
diameter at the aortic isthmus immediately distal to
the left subclavian artery (r = − 0.36, p = 0.01). Finally,
descending aortic distensibility correlated with rate of
change in aortic diameter at proximal aortic arch
between the brachiocephalic and left carotid arteries
(− 0.36, p = 0.03) (Table 5). Omitting all cases with
CoA did not materially change these results (results
not shown).
Mean aortic area was similar among Turner Syndrome
and controls at the ascending and descending sites,
while significantly smaller at the arch (Table 3). How-
ever, when adjusted for BSA, the mean areas was similar
at all sites. Note, however, the much larger variation in
area of the aorta at all studied sites among females with
Turner Syndrome, with some having a clearly smaller
area at all sites, while others had a much larger area at
all sites (Table 3).
Discussion
The principal findings of this study is a significantly re-
duced distensibility of the descending aorta, a higher Aix
and increased central diastolic blood pressure in adult
women with Turner Syndrome compared to sex- and
age-matched controls. The principal determinants of the
abnormal aortic wall properties in Turner Syndrome
were CoA, presence of diabetes, central blood pressure,
Aix and age, whereas other potential contributing factors
such as a bicuspid aortic valve, BMI and BSA did not
emerge as significant contributors.
Aortic distensibility is a measure of aortic elasticity,
which is influenced by factors such as CoA and the
grade of re-coarctation, systemic arterial hypertension
and diabetes [20, 25, 26]. CoA was a principal source of
significantly perturbed distensibility in the ascending
and descending aorta in this cohort of adults with
Turner Syndrome, which is in keeping with a previous
study of CoA in individuals without Turner Syndrome
that showed remodelling of the aorta with increased
Fig. 2 24-h diastolic blood pressure [mmHg] in women with Turner Syndrome and age and gender matched controls. Open circles and dashed
linear fit are Turner Syndrome (24 h diastolic blood pressure = 28.50 + 0.59 x central diastolic blood pressure, r = 0.6, P = 0.001), and filled circles
and full linear fit line are controls (24 h diastolic blood pressure = 37.47 + 0.47 x central diastolic blood pressure, r = 0.6, P = 0.0003)
Table 2 Pulse wave velocity and pulse wave analysis in Turner syndrome and healthy age-matched controls
Turner Syndrome Controls P-value
Augmentation index [%]b 31.4 [27.9–34.9] 24.4 [20.3–28.5] 0.02
Augmentation index [%] without CoAc 31.3 [27.5–35.21] 24.4 [20.3–28.5] 0.04
Pulse wave velocity [m/s]a 6.76 [6.39–7.16] 6.9 [6.56–7.32] 0.6
Central systolic blood pressure [mmHg]b 114.3 ± 13.1 111.3 ± 16.4 0.4
Central diastolic blood pressure [mmHg]b 78.8 ± 9.92 73.7 ± 8.94 0.02
Central systolic blood pressure, central diastolic blood pressure, and Augmentation index were derived from the pulse wave analysis
aTS (n = 62), Controls (n = 38). bTS (n = 49), Controls (n = 34). cTS (n = 41), Controls (n = 34)
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vascular stiffness [27, 28] and a study that showed re-
duced bioelastic properties of the thoracic aorta and also
of left ventricular dysfunction after successful CoA re-
pair in childhood [29]. In our study, we also found an as-
sociation between aortic distensibility and presence of
diabetes and age [30]. This supports the notion that
CoA is part of a disease process spectrum that affects
the entire thoracic aorta [31], and emphasises the need
for comprehensive rather than focal aortic assessments
in the diagnosis and surveillance of aortic disease in
Turner Syndrome [32]. It also points towards age as a
modulating variable, as well as the presence of diabetes
[33]. Conclusively, when all comorbidity has been omit-
ted, the young to middle-aged woman with Turner Syn-
drome may not necessarily have stiffening of the aortic
wall, however the aorta of such a patient may still dilate
due to pathophysiological mechanisms we are not yet
aware of.
Even though aortic stiffness and carotid intima thickness
possibly reflect two separate entities of vascular damage
[34], the two parameters seem significantly correlated
[35]. We have previously shown that women with Turner
Syndrome have abnormal carotid intima thickness [36]
and in this study we found reduced distensibility in
Turner Syndrome women with type 2 diabetes. Therefore,
one must consider whether abnormal vascular function in
Turner Syndrome somehow both reflects an early
atherosclerosis-type process combined with an aortopathy,
associated to the presence of a CoA. On the longer term,
greater arterial stiffness is associated with a higher inci-
dence of atrial fibrillation [37]. The increased arterial stiff-
ness will also lead to reduced impedance mismatch
between aorta and the carotid arteries, spurning remodel-
ling of the cerebral arteries and decreased ability of the
cerebral circulation to adapt to changing flow needs [38].
This will increase the risk of ischemia, both acutely and
chronically, as well as lacunar infarction and white matter
lesions [38, 39], and thus these findings could be one
among many other small steps towards the increased
stroke risk seen in Turner Syndrome [6].
Table 3 Aortic distensibility [mmHg−1], area (mm2) and area/BSA (mm2/(kg/m2)) at each of the three aortic positions in adult
women with TS
Turner Syndrome (n = 57) Controls (n = 36)
Distensibility 0.042a
Ascending 3.27 [2.83–3.77]*10−3 3.74 [3.17–4.41]*10− 3 0.2
Arch 3.45 [3.04–3.92]*10− 3 3.39 [2.93–3.93]*10− 3 0.9
Descending 3.32 [3.01–3.66]*10− 3 4.13 [3.71–4.60]*10− 3 0.02
TS with aortic coarctation (n = 8) TS without aortic coarctation (n = 49)
Distensibility 0.2a
Ascending 2.09 [1.34–3.26]*10−3 3.51 [3.03–4.07]*10− 3 0.003
Arch 2.88 [1.92–4.33]*10− 3 3.56 [3.10–4.08]*10− 3 0.2
Descending 2.25 [1.85–2.74]*10− 3 3.54 [3.20–3.91]*10− 3 0.01
TS without aortic coarc. (n = 49) Controls (n = 36)
Distensibility 0.05a
Ascending 3.51 [3.03–4.07]*10−3 3.74 [3.17–4.41]*10− 3 0.5
Arch 3.56 [3.10–4.08]*10− 3 3.39 [2.93–3.93]*10− 3 0.6
Descending 3.54 [3.20–3.91]*10− 3 4.13 [3.71–4.60]*10− 3 0.1
Area TS (n = 60) Control (n = 37)
Ascending 758.5 [373.5–1499.9] 774.0 [505.4–1220.6] 0.3
Arch 439.3 [272.2–864.1] 497.4 [253.2–717.9] <0.001
Descending 389.8 [211.2–881.2] 410.4 [226.7–711.4] 0.4
Area/BSA TS (n = 60) Control (n = 37)
Ascending 490.8 [256.9–947.6] 434.5 [277.1–624.1] 0.3
Arch 279.3 [172.1–459.2] 278.4 [176.1–388.7] 0.7
Descending 252.3 [151.8–622.7] 230.4 [153.0–356.9] 0.5
First part of the table depicts comparison between all TS and controls. The two middle parts of the table depicts comparison between TS with and without aortic
coarctation, and comparison between TS without coarctation and controls. P-value for interaction overall (group and aortic positiona) as well as comparison
between TS and controls at each position are listed. Lower part of the table depicts mean aortic area and mean aortic area corrected for BSA at the three
aortic positions
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We have followed this cohort of Turner Syndrome
females for a period of 10 years and assessed the rate
of dilation during this period and included distensi-
bility assessment at the latest examination. We found
that higher distensibility in the aortic arch and in the
descending aorta was related to lower rate of change
at two different sites in the descending aorta, pointing to-
wards an effect of normal distensibility in protecting the
aortic wall properties, although clearly longer observation
time with subsequent measurements of both distensibility,
and other aortic wall properties, such as matrix remodel-
ing and perhaps inflammation [40], as well as blood flow
characteristics along the aorta, will be necessary to further
examine these relations.
The reduced aortic distensibility in especially CoA af-
fected Turner Syndrome extends the previous findings
of abnormal aortic function in adolescents with Turner
Syndrome [13, 41] and raises the question if impaired
aortic stiffness precedes aortic dilation as in Marfan syn-
drome [42]. This is particularly important with the cur-
rently used risk markers failing to accurately predict
cases of aortic dissection [20]. Interestingly, all other
Turner Syndrome subgroups (BAV vs. tricuspid aortic
valve, ETA vs. non-ETA, 45,X vs. mosaics) had comparable
aortic distensibility to controls. Likewise, it is possible that
the observed abnormalities of aortic distensibility are in-
fluenced by different blood flow profiles that has been
demonstrated in Turner Syndrome, especially when BAV
or CoA is present [43]. Contrary to the present study, a re-
cent study of Turner Syndrome women found reduced
aortic distensibility when BAV was present, which may
possibly be due differences in the Turner Syndrome popu-
lations studied [44]. Here, we also show that the mean
aortic area is similar or even slightly smaller (aortic arch)
compared with controls, a difference that vanished after
adjustment for BSA, but that the variability in aortic
area is much larger, illustrated by the very wide range.
This observation underscores the fact that the pheno-
typic spectrum of the aorta is larger among females
with Turner Syndrome than among controls.
Smaller studies in children and young adults with Turner
Syndrome previously showed increased PWV and a greater
Aix compared to controls [45, 46]. The present study finds
Fig. 3 Dotplot of aortic distensibility (mmHg− 1) at three positions in the thoracic aorta in women with Turner Syndrome and age and gender
matched controls. Triangles are geometric means with 95% confidence interval. Each dot represents an individual; blue circles are Turner Syndrome
and black circles are controls. P-values for interaction (Group and aortic position) as well as comparison between Turner Syndrome and controls at
each position are given in the plot
Table 4 Determinants of aortic distensibility in the descending
aorta in adult women with Turner syndrome
Beta SE P-value
Central systolic blood pressure −0.00001 0.00002 0.5
Augmentation index −4.8−6 0.00002 0.8
Age −0.0006 0.00003 0.005
Type 2 Diabetes −0.0002 0.0006 0.7
Aortic coarctation −0.001 0.0005 0.03
Multiple linear regression model including central systolic blood pressure, age
and diabetes status, augmentation index (heart rate corrected), and aortic
coarctation shows that only aortic coarctation and age remained significant
explanatory variables to aortic distensibility in adult women with
Turner syndrome
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that adults with Turner Syndrome have a raised Aix but
comparable PWV. A greater Aix indicates increased wave
reflection from the periphery or earlier return of the
reflected wave. Aix is inversely associated with height, and
the lower height in Turner Syndrome compared to con-
trols is an important contributor to the increased Aix ob-
served in Turner Syndrome. Carotid-femoral PWV is an
integrative measure that reflects the average arterial
wall stiffness in the thoracic and abdominal aorta ex-
cluding the ascending aorta, the aortic arch and the ad-
jacent descending aorta. Our data are in line with
previous studies [45, 46] in the observation that
carotid-femoral PWV is comparable between Turner
Syndrome and matched controls, suggesting that this part
of the aorta is not affected in Turner Syndrome. However,
CMR studies evaluating this are lacking. Hypertension is
common in Turner Syndrome with a particularly high
prevalence in adults (up to 50%) [7, 47–49]. Consistent
with this, half of the women with Turner Syndrome in our
study were treated for hypertension. This resulted in com-
parable systolic and mean arterial pressures in Turner
Syndrome and controls, possibly diminishing any differ-
ence in PWV, although the cross-sectional nature of the
study and other differences between Turner Syndrome
and controls, such as frequency of diabetes, precludes any
firm conclusions. Others have found that PWV is not cor-
related with diastolic blood pressure, but with systolic
blood pressure and mean arterial pressure in hypertensive
individuals [50]. Medical intervention may reduce hyper-
tensive wall stress and thus halt any age and disease re-
lated progressive perturbation in aortic wall properties
[51]. However, intervention studies in Turner Syndrome
are lacking [4].
The central diastolic and night-time 24-h ambulatory
diastolic blood pressures were elevated in Turner Syn-
drome, in line with previous findings [47]. In addition to
this, 24-h ambulatory diastolic blood pressure correlated
well with central diastolic blood pressure. The increased
diastolic pressure remains an enigma in Turner Syn-
drome, although it may related to the frequent left
ventricular diastolic dysfunction often seen in Turner
Syndrome [52]. Since increased central and periph-
eral diastolic blood pressure are also associated with
aortic dilatation in the normal population [53], dia-
stolic hypertension should be a target for even more
aggressive treatment in Turner Syndrome, aiming at
halting aortic dilatation, perhaps helping to make
prophylactic aortic surgery a less frequently imple-
mented intervention in TS.
Limitations
The SphygmoCor device uses a generalized transfer
function to derive central blood pressure from radial to-
nometry data. The algorithm used may not be valid in
patients with abnormal arterial function such as CoA.
Therefore, all calculations were done with and without
the individuals with CoA, without resulting in significant
change. The methodology of carotid-femoral pulse wave
velocity measures the mean velocity of the pulse wave in
the thoracic and abdominal aorta and iliac arteries to the
femoral artery. The PWV in the aortic arch is not evalu-
ated by this method. Hence, the carotid-femoral PWV
and the aortic arch distensibility as evaluated by CMR
are complementary. It would also have been advanta-
geous to have compared PWV by SphygmoCor with
PWV determined by phase contrast CMR, and in this
way we could have determined regional alterations in
blood flow dynamics. We plan to do this in future stud-
ies. A proportion of the study cohort, especially among
females with Turner Syndrome, was being treated for
conditions such as hypertension and hypercholesterol-
aemia. This could potentially influence the results. How-
ever, it would be unethical to investigate a similar group
of people without treatment, and the fact that these
Table 5 Correlations between site-specific aortic distensibility and rate of change of aortic diameter during the prior 10 years in
adult women with Turner syndrome. N = 45–48
Distensibility
Ascending Arch Descending
Aortic sinuses r = 0.16, p = 0.3 – –
Sinotubular junction r = −0.15, p = 0.3 – –
Mid-ascending aorta r = 0.02, p = 0.9 – –
Distal ascending aorta r = 0.07, p = 0.7 R = 0.12, p = 0.4 –
Proximal aortic arch – r = −0.16, p = 0.4 r = −0.36, p = 0.03
Distal aortic arch – r = 0.12, p = 0.4 r = 0.04, p = 0.8
Aortic isthmus – r = −0.36, p = 0.01 r = −0.27, p = 0.07
Proximal descending aorta – – r = −0.24, p = 0.1
Distal descending aorta – – r = −0.17, p = 0.3
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women were receiving their usual treatment makes this
study a reflection of a real-life outpatient clinic cohort.
Conclusion
Adult Turner Syndrome females have impaired aortic
wall function of the ascending and descending aorta,
with reduced aortic distensibility among those with
CoA, and higher central and peripheral night-time dia-
stolic blood pressures as well, along with an elevated
Aix. The principal determinant of the abnormal aortic
wall function was the presence of type 2 diabetes, CoA
and age. Measurement of aortic distensibility is a prom-
ising tool in future clinical care of Turner Syndrome in
the prediction of cardiovascular events.
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Additional file 1: Table S1. Aortic distensibility in women with Turner
Syndrome but no aortic coarctation compared to healthy age and
gender matched controls. Overall model P-value < 0.001. No significant
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lower distensibility at the descending aorta. Figure S1. Aortic
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Syndrome with aortic coarctation and black filled are indicate Turner
Syndrome without aortic coarctation. Triangles are geometric means with
95% confidence interval. Figure S2. Aortic distensibility in women with
Turner Syndrome but no aortic coarctation compared to healthy age and
gender matched controls. Dotplot of aortic distensibility (mmHg− 1) at
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are indicate controls Triangles are geometric means with 95% confidence
interval. (DOCX 97 kb)
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